The University of Chicago Header Logo

Connection

Michael Becker to Neoplasm, Residual

Back to Details
This is a "connection" page, showing publications Michael Becker has written about Neoplasm, Residual.
Michael Becker
Connection Strength
0.026
Neoplasm, Residual
  1. SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia. Br J Haematol. 2014 May; 165(4):504-9.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.